Products

99% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487 -28-9

China 99% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-9, Find details about China Rosiptor, 782487-28-9 from 99% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-9

Model NO.
Rosiptor
CAS
782487-28-9
Appearance
White Freeze-Dried Powder
Storage
Room Temperature Away From Light
Shelf Life
24month
Deliver Time
7-10 Days
Trademark
Biocar
Transport Package
10mg/Vials
Specification
10vials/Kit
Origin
Guangzhou China
HS Code
2935900090
Model NO.
Rosiptor
CAS
782487-28-9
Appearance
White Freeze-Dried Powder
Storage
Room Temperature Away From Light
Shelf Life
24month
Deliver Time
7-10 Days
Trademark
Biocar
Transport Package
10mg/Vials
Specification
10vials/Kit
Origin
Guangzhou China
HS Code
2935900090
99% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-9

Detailed Product Information
 
Product Name : Semaglutide
Trade Name: Ozempic/Rybelsus
CAS No.:782487-28-9
Molecular Formula: C20H35NO2
Molecular Weight:321.5g/mol
Purity : 98% HPLC
Appearance:  Lyophilized Powder
Typical use: Type 2 Diabetes Medicine
Shelf Life :2 years
Storage:Refrigeration keep dry and away from light.
99% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-9
Application of Thymalin
  • Treatment of primary and secondary immunodeficiency diseases;
  • Diseases caused by immune dysfunction;
  • Adjuvant tumor therapy;
  • Aplastic anemia, acute and chronic viral hepatitis;
  •  Lupus erythematosus;
  • Rheumatoid arthritis;
  •  Allergic asthma.
COA
 
ItemSpecifications
AppearanceWhite freeze-dried powder
Purity98%min
Boiling point1265.3ºC at 760 mmHg
Density1.27 g/cm3
Refractive index1.638
Single Impurity (HPLC) 1.0%max
Amino Acid Composition ±10% of theoretical
Peptide Content (N%) ≥80.0%
Water Content(Karl Fischer) ≤6.0%
Acetate Content (HPIC)≤12.0%
MS(ESI)Consistent
Mass Balance95.0~105.0%
99% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-999% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-999% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-999% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-999% Rybelsus FDA Approves First Oral GLP-1 Treatment for Type 2 Diabetes Semaglutide Factory Price CAS: 782487-28-9

You Might Also Like